Standard BioTools Inc.
Standard BioTools Inc. (FLDM) Stock Overview
Explore Standard BioTools Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
294.2M
P/E Ratio
-3.94
EPS (TTM)
$-0.78
ROE
-0.28%
FLDM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Standard BioTools Inc. (FLDM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.85.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.94 and a market capitalization of 294.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.